BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Banned: Key Facts on the Latest FDA Decision The trend of unproven peptides is spreading through influencers and RFK Jr. allies CNN Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.